Vaccine success set to put AstraZeneca in pole position
Andrew Baum, a healthcare analyst at Citi, believes that any future financial returns on a successful vaccine is unlikely to...
Andrew Baum, a healthcare analyst at Citi, believes that any future financial returns on a successful vaccine is unlikely to...
